TABLE 5.
Results of scenario-analysis.
| Total cost | QALY | Incremental costs | QALYs gained | ICER | |
| Non-preemptive DDKT | 180,338.83 | 13.65 | |||
| Non-preemptive LRKT | 187,333.70 | 14.12 | 6994.87 | 0.47 | 14,944.42 |
DDKT, deceased-donor kidney transplantation; LRKT, living-related kidney transplantation; ICER, incremental cost-effectiveness ratio; QALYs, quality-adjusted life years.